Other members of the research team at Wake Forest include co-principal investigator Martin Guthold, an associate professor of physics, and Keith Bonin, department chair and professor of physics.
Macosko said the team and their collaborators at the University of Waterloo in Ontario, Canada, are developing a device that will automate the Lab-on-Bead process and permit parallel processing to attain faster screening results. The Wake Forest researchers are also working with biotechnologists at Harvard University in Boston and Université Louis Pasteur in Strasbourg, France, which are providing the chemicals being screened for drug candidates. Biotech company NanoMedica has shown interest in commercializing the process. The North Carolina Biotechnology Center, a private, nonprofit corporation funded by the N.C. General Assembly, has provided $75,000 in funding for the project.
Wake Forest's Center for Nanotechnology and Molecular Materials, which maintains ongoing research programs in the areas of health and medicine, energy technologies and synthesis of nanomaterials, will facilitate some elements of Lab-on-Bead development. ###
Contact: Eric F. Frazier firstname.lastname@example.org 336-758-5237 Wake Forest University
Tags: Nano or Nanotechnology and Nanotech